Working… Menu

RItuximab Versus FUmarate in Newly Diagnosed Multiple Sclerosis. (RIFUND-MS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02746744
Recruitment Status : Completed
First Posted : April 21, 2016
Last Update Posted : October 12, 2021
Information provided by (Responsible Party):
Anders Svenningsson, Karolinska Institutet

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 2021
Actual Study Completion Date : August 2021